- Home
- BPOP vs BPMC Comparison
BPOP vs BPMC Comparison
Compare BPOP & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPOP
- BPMC
- Stock Information
- Founded
- BPOP 1893
- BPMC 2008
- Country
- BPOP United States
- BPMC United States
- Employees
- BPOP N/A
- BPMC N/A
- Industry
- BPOP Major Banks
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- BPOP Finance
- BPMC Health Care
- Exchange
- BPOP Nasdaq
- BPMC Nasdaq
- Market Cap
- BPOP 5.9B
- BPMC 5.8B
- IPO Year
- BPOP N/A
- BPMC 2015
- Fundamental
- Price
- BPOP $100.49
- BPMC $98.76
- Analyst Decision
- BPOP Buy
- BPMC Buy
- Analyst Count
- BPOP 6
- BPMC 21
- Target Price
- BPOP $110.67
- BPMC $124.05
- AVG Volume (30 Days)
- BPOP 626.6K
- BPMC 1.0M
- Earning Date
- BPOP 04-23-2025
- BPMC 05-01-2025
- Dividend Yield
- BPOP 2.79%
- BPMC N/A
- EPS Growth
- BPOP 43.88
- BPMC N/A
- EPS
- BPOP 9.68
- BPMC N/A
- Revenue
- BPOP $2,735,868,000.00
- BPMC $562,121,000.00
- Revenue This Year
- BPOP N/A
- BPMC $44.85
- Revenue Next Year
- BPOP $6.55
- BPMC $32.06
- P/E Ratio
- BPOP $10.38
- BPMC N/A
- Revenue Growth
- BPOP 6.94
- BPMC 99.19
- 52 Week Low
- BPOP $78.23
- BPMC $73.04
- 52 Week High
- BPOP $106.81
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- BPOP 68.70
- BPMC 62.93
- Support Level
- BPOP $97.08
- BPMC $87.03
- Resistance Level
- BPOP $100.53
- BPMC $104.86
- Average True Range (ATR)
- BPOP 2.55
- BPMC 3.73
- MACD
- BPOP 1.00
- BPMC 1.65
- Stochastic Oscillator
- BPOP 93.71
- BPMC 71.75
About BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.